Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 10/10/2019 2:10:13 AM - Followers: 39 - Board type: Free - Posts Today: 0
MRK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRK News: Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA® (pembrolizumab) as First-Line Treatment for Metast... 07:00 AM
MRK News: Merck Receives EU CHMP Positive Opinion for Investigational V920 Ebola Zaire Vaccine for Protection Against Ebola Virus Disea... 06:45 AM
MRK News: BriaCell Announces Closing of Non-Brokered Private Placement of $568,444 10/15/2019 05:33:25 PM
MRK News: BriaCell Therapeutics Corp. to File Amendment to Management Information Circular 10/08/2019 07:00:00 PM
MRK News: Merck Issues 2018/2019 Corporate Responsibility Report 10/08/2019 08:00:00 AM
News News Alert: Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA® (pembrolizumab) as First-Line Treatment for Metast... 10/18/2019 07:00:00 AM
PostSubject
#468  Sticky Note MRK Investor Day items… DewDiligence 06/20/19 08:36:00 AM
#491   https://oncologie.international/oncologie-announces-first-patient-enrolled-in-global-phase-2-study-o north40000 10/10/19 02:10:13 AM
#490   Dew, The fact that higher blood EPA levels couldbebetter 10/04/19 10:03:01 PM
#489   "A combination with Zocor[a statin] might make sense, north40000 10/04/19 08:58:05 PM
#488   Would clinical trials that involve Amarin’s Vascepa and DewDiligence 10/04/19 08:13:54 PM
#487   Would clinical trials that involve Amarin’s Vascepa and north40000 10/04/19 08:10:44 PM
#486   Well if not there ... at least on Whalatane 10/04/19 07:05:13 PM
#485   North. You and Dew are. “ trending Whalatane 10/04/19 07:03:45 PM
#484   AMRN— I sure would love to see Vascepa DewDiligence 10/04/19 05:53:26 PM
#483   MRK: Views on a future MRK acquisition, AMRN north40000 10/04/19 03:57:09 PM
#482   Keytruda active in neoadjuvant/adjuvant TNBC— (KEYNOTE-522 interim results): DewDiligence 09/29/19 11:33:04 AM
#481   News: $MRK 2 Pharma Stocks You Should Buy Now whytestocks 09/21/19 03:50:26 PM
#480   FDA approves Pifeltro and Delstrigo for HIV “switch” patients: DewDiligence 09/20/19 12:28:09 PM
#479   FDA approves Keytruda/Lenvima in second-line endometrial cancer: DewDiligence 09/17/19 07:26:07 PM
#478   No (eom). DewDiligence 09/10/19 08:43:35 AM
#477   Is mrk buying nwbo jdheart101 09/10/19 08:41:16 AM
#476   $mrk...strong buying continues as chart continues to chris20 08/19/19 02:44:52 PM
#475   MRK 2Q19 CC transcript: DewDiligence 07/31/19 10:35:21 AM
#474   FDA approves Keytruda monotherapy in second-line esophageal cancer DewDiligence 07/31/19 10:34:46 AM
#473   2019 non-GAAP EPS guidance raised to $4.84-4.94 (from DewDiligence 07/30/19 08:13:49 AM
#472   Keytruda 2Q19 sales +63% YoY in constant currency DewDiligence 07/30/19 08:08:47 AM
#471   MRK 2Q19 items… DewDiligence 07/30/19 07:48:57 AM
#470   MRK—Keytryda/chemo shows statig-better pCR than chemo alone in DewDiligence 07/29/19 10:55:27 AM
#469   $MRK Merck & CO Inc. still in 19 TopMarketGainers 06/26/19 04:23:32 PM
#468   MRK Investor Day items… DewDiligence 06/20/19 08:36:00 AM
#467   FDA approves Keytruda monotherapy in third-line SCLC: DewDiligence 06/18/19 11:09:39 AM
#466   FDA approves Keytruda in HNSCC with/without chemo— based DewDiligence 06/11/19 11:44:34 AM
#465   MRK acquires (private) Tilos Therapeutics for $773M (including DewDiligence 06/10/19 07:19:27 AM
#464   Oh yeah well how about this comment to wrenchman 06/07/19 04:16:18 AM
#463   Sorry, my link to the John C Peoples Almost A Myth 06/06/19 10:27:20 PM
#462   Ok. Thank you. I think it's of huge Almost A Myth 06/06/19 09:28:50 PM
#461   ...you think it's of no significance?Correct. DewDiligence 06/06/19 09:12:26 PM
#460   Utter nonsense as in you don't think the Almost A Myth 06/06/19 09:09:06 PM
#459   You are absolutely right United4ever. The fact Kgem 06/06/19 08:58:52 PM
#458   I think that it is worth doing some united4ever 06/06/19 08:39:59 PM
#457   Not certain MLR Lite. As more news Kgem 06/06/19 08:24:45 PM
#456   DD, respectfully you should at least give your united4ever 06/06/19 08:19:58 PM
#455   What part was supposed to be nonsense? MLR_Lite 06/06/19 08:15:20 PM
#454   Okay DD. I thought MRK investors might Kgem 06/06/19 02:49:15 PM
#453   Utter nonsense (eom). DewDiligence 06/06/19 02:44:52 PM
#452   Merck (MRK) is rumored to have a deal Kgem 06/06/19 02:30:22 PM
#451   LH poaches MRK executive, Adam Schechter for new CEO: DewDiligence 06/06/19 12:08:51 PM
#450   MRK acquires—(private)—Peloton Therapeutics for $1.05B up-front and $1.15B DewDiligence 05/21/19 10:05:47 AM
#449   Keytruda monotherapy fails to show OS benefit vs DewDiligence 05/20/19 04:55:13 PM
#448   MRK 1Q19 CC transcript: DewDiligence 05/01/19 09:43:48 AM
#447   MRK 1Q19 items… DewDiligence 04/30/19 07:59:46 AM
#445   Keytruda phase-3 results in first-line gastric cancer: i) DewDiligence 04/26/19 11:41:53 AM
#443   Out for the weekend. The recovery bounce ASPD_Capital 04/26/19 09:37:54 AM
#442   Alright, cautious optimism it is. In long ASPD_Capital 04/23/19 09:57:48 AM
#441   Still trying to figure out if the bleeding ASPD_Capital 04/22/19 01:51:44 PM
#440   FDA approves Ketyruda/Inlyta in 1L-RCC: DewDiligence 04/22/19 10:21:09 AM
PostSubject